tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Acrivon Therapeutics reports Q2 EPS (55c), consensus (58c)
PremiumThe FlyAcrivon Therapeutics reports Q2 EPS (55c), consensus (58c)
24d ago
Acrivon Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
Acrivon Therapeutics Holds Annual Stockholders Meeting
3M ago
Acrivon Therapeutics: Promising Clinical Developments and Strategic Focus Support Buy Rating
Premium
Ratings
Acrivon Therapeutics: Promising Clinical Developments and Strategic Focus Support Buy Rating
4M ago
Optimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer
PremiumRatingsOptimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer
4M ago
Acrivon Therapeutics  reports Q1 EPS (51c), consensus (65c)
Premium
The Fly
Acrivon Therapeutics reports Q1 EPS (51c), consensus (65c)
4M ago
Acrivon Therapeutics sees cash, equivalents funding expenses into 2Q27
Premium
The Fly
Acrivon Therapeutics sees cash, equivalents funding expenses into 2Q27
4M ago
Acrivon Therapeutics Reports Progress in Cancer Drug Development
PremiumCompany AnnouncementsAcrivon Therapeutics Reports Progress in Cancer Drug Development
5M ago
Acrivon Therapeutics Appoints New Chief Medical Officer
Premium
Company Announcements
Acrivon Therapeutics Appoints New Chief Medical Officer
5M ago
Acrivon appoints Mansoor Raza Mirza as Chief Medical Officer
Premium
The Fly
Acrivon appoints Mansoor Raza Mirza as Chief Medical Officer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100